RedHill Biopharma's stock surged on Nasdaq following the divestment of its Talicia business to Apotex for $18M, while future products seek FDA approval.

The entities involved

• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Apotex →

  Canadian private pharmaceutical company

  • A settlement involving drug manufacturers was announced by Andy Wilson after the U.S. District Court for Connecticut approved the plan.Sat 02:43
  • Generic drug shortages and supply chain failure are currently affecting the Quebec market.Thu 11:32

Related events

• Alvotech utilized Nasdaq for its public stock listing and is currently undergoing comprehensive review by the FDA for biosimilar applications.Aug 19
• Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.Sep 10
• Acurx Pharmaceuticals trades on NASDAQ and is receiving FDA guidance supporting its potential approval pathway.Aug 16
• Palvella Therapeutics, Inc. stock is trading on the Nasdaq exchange, and the NDA review for its product QTORIN is currently underway.Aug 4
• BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.Jul 31